CORRECTION article

Front. Immunol., 20 February 2024

Sec. Inflammation

Volume 15 - 2024 | https://doi.org/10.3389/fimmu.2024.1382832

Corrigendum: Identification of ACKR4 as an immune checkpoint in pulmonary arterial hypertension

  • 1. Shanghai Clinical Research Center for Rare Pediatric Diseases, Shanghai Children’s Medical Center (SCMC), School of Medicine, Shanghai Jiao Tong University, Shanghai, China

  • 2. Heart Center and Shanghai Institute of Pediatric Congenital Heart Disease, Shanghai Children’s Medical Center (SCMC), School of Medicine, Shanghai Jiao Tong University, Shanghai, China

  • 3. School of Pharmacy, Henan University, Kaifeng, Henan, China

  • 4. School of Biomedical Engineering, Shanghaitech University, Shanghai, China

In the original article, there was a mistake in the Funding statement as published. The Projects of National Natural Science Foundation of China (82200065, 82000064) were wrong. The correct Funding statement appears below.

FUNDING

“This work was supported by the Project of National Natural Science Foundation of China (U20A2018), the Project of Shanghai Municipal Science and Technology Commission (20MC1920400), the National Key Research and Development Program of China (2022YFC2703102), Projects of National Natural Science Foundation of China (82200065, 82241007), Shanghai Pujiang Program (22PJ1410100), Young Talent Program of Shanghai Municipal Health Commission (2022YQ070) and Innovative research team of high-level local universities in Shanghai.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

pulmonary arterial hypertension, atypical chemokine receptor 4, transcriptomics, chemokines, immune

Citation

Jiang C-Y, Wu L-W, Liu Y-W, Feng B, Ye L-C, Huang X, He Y-Y, Shen Y, Zhu Y-F, Zhou X-L, Jiang D-J, Qi H-K, Zhang H and Yan Y (2024) Corrigendum: Identification of ACKR4 as an immune checkpoint in pulmonary arterial hypertension. Front. Immunol. 15:1382832. doi: 10.3389/fimmu.2024.1382832

Received

06 February 2024

Accepted

07 February 2024

Published

20 February 2024

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

15 - 2024

Updates

Copyright

*Correspondence: Yi Yan, ; Hao Zhang, ; Hai-Kun Qi,

†These authors have contributed equally to this work and share first authorship

‡These authors have contributed equally to this work and share last authorship

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics